Advertisement

Topics

Valeant completes sale of Dendreon to Sanpower for $819.9m

19:00 EDT 2 Jul 2017 | Pharmaceutical Technology

Canadian company Valeant Pharmaceuticals International has completed the sale of all outstanding equity interests in its subsidiary Dendreon Pharmaceuticals to the Sanpower Group for $819.9m.

Original Article: Valeant completes sale of Dendreon to Sanpower for $819.9m

NEXT ARTICLE

More From BioPortfolio on "Valeant completes sale of Dendreon to Sanpower for $819.9m"

Advertisement
Quick Search
Advertisement
Advertisement